Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes MellitusJanuary 3, 2025Psoriasis
Dermatology NewsCombined Clinics, Personalized Medicine for Psoriatic Disease Face BarriersJanuary 2, 2025Psoriatic ArthritisPsoriasis
Dermatology NewsFDA Approves Ustekinumab Biosimilar Steqeyma, the Seventh of Its KindDecember 19, 2024Psoriatic ArthritisPsoriasis
Dermatology NewsGeriatric Dermatology: Q&A With Daniel C. Butler, MDDecember 11, 2024Medical DermatologyActinic KeratosisAtopic DermatitisDermatologic SurgeryDermatopathologyPsoriasisNonmelanoma Skin Cancer
Successful Treatment of Severe Dystrophic Nail Psoriasis With DeucravacitinibDecember 3, 2024Psoriasis
Dermatology NewsAdalimumab for Psoriasis: Study Compares Biosimilars Vs. OriginatorDecember 2, 2024PsoriasisPsoriatic Arthritis
Dermatology NewsPost COVID-19, Long-term Risk for Autoimmune, Autoinflammatory Skin Disorders Increased, Study FindsNovember 20, 2024Autoimmune DiseasesPsoriasisHair & NailsInfectious DiseasesMixed Topics
Dermatology NewsUpdated Guidance for Psoriatic Arthritis Ultrasound Comes at Time of Growing Use, New TechnologyNovember 18, 2024Psoriatic ArthritisPsoriasis
Eating Disorder Risk Factors and the Impact of Obesity in Patients With PsoriasisNovember 8, 2024Psoriasis
Projected 2023 Cost Reduction From Tumor Necrosis Factor α Inhibitor Biosimilars in Dermatology: A National Medicare AnalysisOctober 21, 2024Psoriasis
Considerations for the Use of Biologics in PregnancyOctober 4, 2024PsoriasisAutoimmune DiseasesAtopic Dermatitis
Treat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque PsoriasisOctober 4, 2024Psoriasis
Dermatology NewsStudy Supports Efficacy of Home-Based Phototherapy for PsoriasisOctober 3, 2024PsoriasisPsoriatic Arthritis
Dermatology NewsBimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial SpondyloarthritisSeptember 24, 2024Psoriatic ArthritisPsoriasis
